Outcome data reported in Cochrane Eyes and Vision reviews

Project Summary Title and Description

Title
Outcome data reported in Cochrane Eyes and Vision reviews
Description
N/A
Attribution
N/A
Authors of Report
N/A
Methodology description
N/A
PROSPERO
N/A
DOI
10.26300/cg4t-sv98
Notes
N/A
Funding Source
N/A

Key Questions

1. What outcome data from trials are reported in Cochrane Eyes and Vision reviews

Associated Extraction Forms

Associated Studies (each link opens a new tab)

TitleAuthorsYear
5-Fluorouracil for glaucoma surgery.
Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma.
Accommodative intraocular lens versus standard monofocal intraocular lens implantation in cataract surgery.
Acupuncture for acute hordeolum.
Acupuncture for glaucoma.
Acupuncture for slowing the progression of myopia in children and adolescents.
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
Adjustable versus non-adjustable sutures for strabismus.
Aflibercept for neovascular age-related macular degeneration.
Amniotic membrane transplantation for acute ocular burns.
Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration.
Antibiotics for trachoma.
Antibiotics versus no treatment for toxoplasma retinochoroiditis.
Antibiotics versus placebo for acute bacterial conjunctivitis.
Antimetabolites in cataract surgery to prevent failure of a previous trabeculectomy.
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract.
Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Anti-vascular endothelial growth factor for neovascular glaucoma.
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.
Aqueous shunts for glaucoma.
Artificial corneas versus donor corneas for repeat corneal transplants.
Aspirin as adjunctive treatment for giant cell arteritis.
Assistive technology for children and young people with low vision.
Autologous serum eye drops for dry eye.
Beta radiation for glaucoma surgery.
Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.
Blood pressure control for diabetic retinopathy.
Botulinum toxin for the treatment of strabismus.
Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma.
Community screening for visual impairment in the elderly.
Complement inhibitors for age-related macular degeneration.
Conjunctival autograft for pterygium.
Conventional occlusion versus pharmacologic penalization for amblyopia.
Corneal collagen cross-linking for treating keratoconus.
Corticosteroid implants for chronic non-infectious uveitis.
Corticosteroids as adjuvant therapy for ocular toxoplasmosis.
Corticosteroids for treating optic neuritis.
Day care versus in-patient surgery for age-related cataract.
Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus.
Device-modified trabeculectomy for glaucoma.
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Educational interventions for the prevention of eye injuries.
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction.
Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy.
Environmental and behavioural interventions for reducing physical activity limitation in community-dwelling visually impaired older people.
Environmental sanitary interventions for preventing active trachoma.
Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia.
Face washing promotion for preventing active trachoma.
Face-down positioning or posturing after macular hole surgery.
Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery.
Focal laser treatment in addition to chemotherapy for retinoblastoma.
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.
Ginkgo biloba extract for age-related macular degeneration.
Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.
Integrated versus non-integrated orbital implants for treating anophthalmic sockets.
Interventions for acute non-arteritic central retinal artery occlusion.
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment.
Interventions for central serous chorioretinopathy: a network meta-analysis.
Interventions for chronic blepharitis.
Interventions for dissociated vertical deviation.
Interventions for idiopathic intracranial hypertension.
Interventions for improving adherence to ocular hypotensive therapy.
Interventions for infantile esotropia.
Interventions for intermittent exotropia.
Interventions for involutional lower lid entropion.
Interventions for late trabeculectomy bleb leak.
Interventions for Mooren's ulcer.
Interventions for prevention of giant retinal tear in the fellow eye.
Interventions for recurrent corneal erosions.
Interventions for strabismic amblyopia.
Interventions for trachoma trichiasis.
Interventions for unilateral and bilateral refractive amblyopia.
Interventions to slow progression of myopia in children.
Intra-operative mitomycin C for glaucoma surgery.
Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
Intravitreal steroids for macular edema in diabetes.
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Ivermectin for onchocercal eye disease (river blindness).
Laser peripheral iridoplasty for angle-closure.
Laser photocoagulation for choroidal neovascularisation in pathologic myopia.
Laser photocoagulation for neovascular age-related macular degeneration.
Laser photocoagulation for proliferative diabetic retinopathy.
Laser trabeculoplasty for open angle glaucoma.
Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.
Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.
Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.
Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.
Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.
Lens extraction for chronic angle-closure glaucoma.
Macular grid laser photocoagulation for branch retinal vein occlusion.
Macular translocation for neovascular age-related macular degeneration.
Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract.
Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for age-related cataract.
Medical interventions for acanthamoeba keratitis.
Medical interventions for fungal keratitis.
Medical interventions for primary open angle glaucoma and ocular hypertension.
Medical interventions for traumatic hyphema.
Medical versus surgical interventions for open angle glaucoma.
Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.
Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma.
Multifocal versus monofocal intraocular lenses after cataract extraction.
N-acetylcarnosine (NAC) drops for age-related cataract.
Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.
Needling for encapsulated trabeculectomy filtering blebs.
Neuroprotection for treatment of glaucoma in adults.
Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma.
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery.
Non-surgical interventions for acute internal hordeolum.
Non-surgical interventions for convergence insufficiency.
Occlusion for stimulus deprivation amblyopia.
Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration.
Optical reading aids for children and young people with low vision.
Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts.
Orbital radiotherapy for adult thyroid eye disease.
Orientation and mobility training for adults with low vision.
Over the counter (OTC) artificial tear drops for dry eye syndrome.
Patching for corneal abrasion.
Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery.
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Peripheral iridotomy for pigmentary glaucoma.
Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract.
Photodynamic therapy for neovascular age-related macular degeneration.
Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction.
Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.
Probing for congenital nasolacrimal duct obstruction.
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.
Psychosocial interventions for improving quality of life outcomes in adults undergoing strabismus surgery.
Punctal occlusion for dry eye syndrome.
Radiotherapy for neovascular age-related macular degeneration.
Reading aids for adults with low vision.
Rituximab for thyroid-associated ophthalmopathy.
Routine preoperative medical testing for cataract surgery.
Screening for prevention of optic nerve damage due to chronic open angle glaucoma.
Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children.
Statins for age-related macular degeneration.
Steroids for traumatic optic neuropathy.
Strabismus surgery before versus after completion of amblyopia therapy in children.
Sublingual immunotherapy for treating allergic conjunctivitis.
Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration.
Surgery for cataracts in people with age-related macular degeneration.
Surgery for nonarteritic anterior ischemic optic neuropathy.
Surgery for post-vitrectomy cataract.
Surgery for traumatic optic neuropathy.
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Surgical interventions for age-related cataract.
Surgical interventions for bilateral congenital cataract.
Surgical interventions for primary congenital glaucoma.
Surgical orbital decompression for thyroid eye disease.
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.
Systemic treatment for blepharokeratoconjunctivitis in children.
Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
Telerehabilitation for people with low vision.
Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
Topical corticosteroids as adjunctive therapy for bacterial keratitis.
Topical cyclosporine for atopic keratoconjunctivitis.
Topical medication instillation techniques for glaucoma.
Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema.
Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions.
Topical treatments for blepharokeratoconjunctivitis in children.
Types of intraocular lenses for cataract surgery in eyes with uveitis.
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.
Vision screening for amblyopia in childhood.2009
Screening for correctable visual acuity deficits in school-age children and adolescents.
Vitamin A and fish oils for retinitis pigmentosa.
Vitrectomy for idiopathic macular hole.
Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH).
Acupuncture for acute hordeolum.2014
Acupuncture for slowing the progression of myopia in children and adolescents.2011
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
Adjustable versus non-adjustable sutures for strabismus.
Aflibercept for neovascular age-related macular degeneration.
Amniotic membrane transplantation for acute ocular burns.
Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration.
Antibiotics for trachoma.
Antibiotics versus no treatment for toxoplasma retinochoroiditis.
Antibiotics versus placebo for acute bacterial conjunctivitis.
Antimetabolites in cataract surgery to prevent failure of a previous trabeculectomy.
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract.
Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.2014
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Anti-vascular endothelial growth factor for neovascular glaucoma.
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.
Aqueous shunts for glaucoma.
Artificial corneas versus donor corneas for repeat corneal transplants.
Aspirin as adjunctive treatment for giant cell arteritis.
Assistive technology for children and young people with low vision.
Beta radiation for glaucoma surgery.
Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.
Blood pressure control for diabetic retinopathy.
Botulinum toxin for the treatment of strabismus.
Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma.
Community screening for visual impairment in the elderly.
Complement inhibitors for age-related macular degeneration.
Conjunctival autograft for pterygium.
Conventional occlusion versus pharmacologic penalization for amblyopia.2009
Corneal collagen cross-linking for treating keratoconus.
Corticosteroid implants for chronic non-infectious uveitis.
Corticosteroids as adjuvant therapy for ocular toxoplasmosis.
Corticosteroids for treating optic neuritis.
Day care versus in-patient surgery for age-related cataract.
Deep anterior lamellar keratoplasty versus penetrating keratoplasty for treating keratoconus.
Device-modified trabeculectomy for glaucoma.
Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Endonasal versus external dacryocystorhinostomy for nasolacrimal duct obstruction.
Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy.
Environmental and behavioural interventions for reducing physical activity limitation in community-dwelling visually impaired older people.
Environmental sanitary interventions for preventing active trachoma.
Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia.2014
Face washing promotion for preventing active trachoma.
Face-down positioning or posturing after macular hole surgery.
Fibrin glue versus sutures for conjunctival autografting in primary pterygium surgery.
Focal laser treatment in addition to chemotherapy for retinoblastoma.
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.
Ginkgo biloba extract for age-related macular degeneration.
Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.
Integrated versus non-integrated orbital implants for treating anophthalmic sockets.
Interventions for acute non-arteritic central retinal artery occlusion.2009
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment.
Interventions for central serous chorioretinopathy: a network meta-analysis.
Interventions for chronic blepharitis.
Interventions for dissociated vertical deviation.
Interventions for improving adherence to ocular hypotensive therapy.2013
Interventions for infantile esotropia.
Interventions for intermittent exotropia.
Interventions for involutional lower lid entropion.
Interventions for late trabeculectomy bleb leak.
Interventions for Mooren's ulcer.
Interventions for prevention of giant retinal tear in the fellow eye.
Interventions for recurrent corneal erosions.
Interventions for strabismic amblyopia.
Interventions for trachoma trichiasis.
Interventions for unilateral and bilateral refractive amblyopia.2012
Interventions to slow progression of myopia in children.
Intra-operative mitomycin C for glaucoma surgery.
Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
Intravitreal steroids for macular edema in diabetes.2008
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.2015
Ivermectin for onchocercal eye disease (river blindness).
Laser peripheral iridoplasty for angle-closure.
Laser photocoagulation for choroidal neovascularisation in pathologic myopia.2005
Laser photocoagulation for neovascular age-related macular degeneration.
Laser photocoagulation for proliferative diabetic retinopathy.
Laser trabeculoplasty for open angle glaucoma.
Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.2015
Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.
Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.
Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.
Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.
Lens extraction for chronic angle-closure glaucoma.
Macular grid laser photocoagulation for branch retinal vein occlusion.
Macular translocation for neovascular age-related macular degeneration.2008
Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract.
Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for age-related cataract.
Medical interventions for acanthamoeba keratitis.
Medical interventions for fungal keratitis.
Medical interventions for primary open angle glaucoma and ocular hypertension.2007
Medical interventions for traumatic hyphema.
Medical versus surgical interventions for open angle glaucoma.
Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery.
Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma.2014
Multifocal versus monofocal intraocular lenses after cataract extraction.2016
N-acetylcarnosine (NAC) drops for age-related cataract.
Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.
Needling for encapsulated trabeculectomy filtering blebs.2012
Neuroprotection for treatment of glaucoma in adults.
Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma.
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery.
Non-surgical interventions for acute internal hordeolum.
Non-surgical interventions for convergence insufficiency.2011
Occlusion for stimulus deprivation amblyopia.
Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration.
Optical reading aids for children and young people with low vision.
Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts.
Orbital radiotherapy for adult thyroid eye disease.2012
Orientation and mobility training for adults with low vision.
Over the counter (OTC) artificial tear drops for dry eye syndrome.
Patching for corneal abrasion.
Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery.
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Peripheral iridotomy for pigmentary glaucoma.
Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract.
Photodynamic therapy for neovascular age-related macular degeneration.2007
Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correction.2012
Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments.
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.
Psychosocial interventions for improving quality of life outcomes in adults undergoing strabismus surgery.
Punctal occlusion for dry eye syndrome.2017
Radiotherapy for neovascular age-related macular degeneration.2010
Reading aids for adults with low vision.
Rituximab for thyroid-associated ophthalmopathy.
Routine preoperative medical testing for cataract surgery.2012
Screening for prevention of optic nerve damage due to chronic open angle glaucoma.
Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children.2014
Statins for age-related macular degeneration.
Steroids for traumatic optic neuropathy.
Strabismus surgery before versus after completion of amblyopia therapy in children.
Sublingual immunotherapy for treating allergic conjunctivitis.
Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration.
Surgery for cataracts in people with age-related macular degeneration.
Surgery for nonarteritic anterior ischemic optic neuropathy.
Surgery for post-vitrectomy cataract.
Surgery for traumatic optic neuropathy.2013
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.2013
Surgical interventions for age-related cataract.2006
Surgical interventions for bilateral congenital cataract.
Surgical interventions for primary congenital glaucoma.
Surgical orbital decompression for thyroid eye disease.
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.2014
Systemic treatment for blepharokeratoconjunctivitis in children.
Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
Telerehabilitation for people with low vision.2015
Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
Topical corticosteroids as adjunctive therapy for bacterial keratitis.
Topical cyclosporine for atopic keratoconjunctivitis.
Topical medication instillation techniques for glaucoma.
Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema.
Topical non-steroidal anti-inflammatory drugs for analgesia in traumatic corneal abrasions.
Types of intraocular lenses for cataract surgery in eyes with uveitis.2014
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.
Screening for correctable visual acuity deficits in school-age children and adolescents.2005
Vitamin A and fish oils for retinitis pigmentosa.
Vitrectomy for idiopathic macular hole.2015
Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH).
5-Fluorouracil for glaucoma surgery.
Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma.2016
Acupuncture for glaucoma.

Downloadable Data Content

Files
  • XLSX Project Data